Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

North Karelia Wellbeing Services County adopts Nightingale Health’s disease risk assessment as part of public healthcare in Finland

Nightingale Health

Nightingale Health Plc | Press Release | December 18, 2025 at 15:00:00 EET

The Finnish North Karelia Wellbeing Services County is piloting Nightingale Health’s blood analysis as part of health checks for unemployed – the aim is to create a cost-effective and impactful model for preventive health.

Nightingale Health’s goal is to develop a cost-effective and impactful healthcare model that helps allocate healthcare resources and strengthens preventive healthcare within the Wellbeing Services County. This pilot will generate valuable data on disease risks, changes in risk, and the effectiveness of interventions, supporting evidence-based decision-making.

Health checks for unemployed are a statutory service designed to assess and promote the health and wellbeing of unemployed and support their work ability. The service is based on the Finnish Health Care Act and is intended for individuals who are not covered by occupational or student healthcare.

Nightingale Health’s technology is already widely used in the private sector, including in occupational health services provided by Terveystalo, Finland’s largest private healthcare provider. Earlier this autumn, Nightingale Health announced the expansion of the use of its technology in the private sector to all Terveystalo customer segments. Now, the technology is being introduced in public healthcare for a second Wellbeing Services County, first being the Wellbeing Services County of South Savo, further accelerating equal and effective preventive healthcare in Finland.

“Nightingale’s technology offers a unique and cost-effective way to identify disease risks and target preventive measures at the population level. It’s great that North Karelia’s Wellbeing Services County is joining in to set an example of how preventive healthcare can be implemented broadly and effectively as part of primary care,” says Teemu Suna, CEO and founder of Nightingale Health.

“We need smarter ways to keep people healthy. With this pilot, as part of developing the health check process for unemployed, we want to pilot earlier identification of disease risks and provide both healthcare professionals and individuals with clear, practical information about personal health. Starting with health checks for unemployed makes sense – they are already part of statutory care and offer a natural platform for developing preventive services,” says Susanna Wilén, Director of Service Area at the North Karelia Wellbeing Services County.

The project will begin immediately with a preparatory phase, with the goal of starting to offer Nightingale Health’s test as part of health checks for unemployed in the first half of 2026.

For further information, please contact
Teemu Suna, CEO
ir@nightingalehealth.com

About Nightingale Health
At Nightingale Health, we believe there is a way to make healthcare better for everyone. We can reduce costs for payers and ease the burden on healthcare professionals while helping people live long and healthy lives. This is possible by introducing a healthcare logic built on prevention, where the aim is to reduce the number of sick people. That is why we have created the Nightingale Health Check. With every blood sample, we make better healthcare possible for everyone.

Nightingale Health operates globally with a parent company in Finland and subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom. Nightingale Health has customers in more than 34 countries in the healthcare and medical research sectors. The Company's technology is being used in many of the world's leading health initiatives, such as the UK Biobank, and over 900 peer-reviewed publications validate the technology. The company's Series B shares are listed on the Main Market of Nasdaq Helsinki and on the OTCQX International market. Read more: https://nightingalehealth.com/

Image Attachments
Nightingale Health

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.